1.THE RETROSIGMOIDAL APPROACH IN OTONEUROLOGICAL SURGERY
Peizhi WANG ; Jie WANG ; Shunwang ZHANG ; Deqing XU ; Jinyue SHI
Medical Journal of Chinese People's Liberation Army 1983;0(02):-
Otoneurological operations were performed in 96 patients through the retrosigmoidal approach. The anatomical structures in the cerebello-pontine angle can be clearly exposed with this procedure. The approach has the advantage that it is of convenience in manipulation with only gentle trauma, and that some drawbacks of suboccipital or retrolabyrimhine approach may be overcome. On the other hand, operation indications can be extended and operation complications reduced. It is an ideal approach which enters the cerebello-pontine angle. The surgical technique and clinical experience have been reported in detail in this paper.
2. Study on bioequivalence evaluation of dexamethasone acetate tablets in Chinese healthy volunteers
Lei XIAO ; Xiaoqing HUANG ; Wen ZHANG ; Yang CAO ; Shunwang HUANG ; Yuanyuan XU ; Jing XIE ; Huan ZHOU
Chinese Journal of Clinical Pharmacology and Therapeutics 2023;28(12):1365-1371
AIM: To assess the bioequivalence of oral dexamethasone acetate tablets between the test and reference formulations in healthy adult Chinese subjects on an empty stomach and after meals. METHODS: A randomized, open, single-dose, two-cycle double crossover bioequivalence study was followed. Twenty-four healthy subjects were included in the fasting group, and 32 healthy subjects were included in the postprandial group, taking 2 tablets (0.75 mg/tablet) of the test formulation (T) or 3 tablets (0.50 mg/tablet) of the reference formulation (R) per cycle for two cycles. The concentrations of dexamethasone acetate in human plasma were determined using liquid chromatography-mass spectrometry, and the pharmacokinetic parameters were calculated according to the non-atrial model using WinNonlin 8.0 software.The bioequivalence of both the test formulation and the reference formulation was evaluated. RESULTS: The pharmacokinetic parameters after oral administration of dexamethasone acetate tablets in a fasted state in subjects with the reference formulation are as follows: Tmax 1.13 (0.50, 4.00) and 1.00 (0.50, 5.00) h, AUC0-t (72.25±21.55) and (69.23±17.76) ng · mL